Related Party Transactions (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | 36 Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 15, 2026 |
Aug. 17, 2026 |
Jun. 23, 2026 |
Mar. 26, 2026 |
May 08, 2023 |
Aug. 29, 2022 |
Aug. 29, 2022 |
Jul. 26, 2022 |
Oct. 13, 2021 |
Sep. 10, 2020 |
Sep. 30, 2026 |
Jan. 31, 2021 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
May 08, 2026 |
Aug. 31, 2025 |
|
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Fair value of marketable securities | $ 613,000 | $ 613,000 | $ 613,000 | $ 2,694,000 | |||||||||||||||
| Unrealized gain loss on investments | (14,077,000) | (17,172,000) | |||||||||||||||||
| Number of shares issued | 703,000 | ||||||||||||||||||
| Interest expense | 113,000 | $ 38,000 | $ 241,000 | $ 194,000 | |||||||||||||||
| Securities Purchase Agreement [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Interest rate | 3.00% | ||||||||||||||||||
| Converted outstanding price | $ 0.50 | $ 0.45 | $ 0.74 | ||||||||||||||||
| Purchase of warrant | 16,554,055 | ||||||||||||||||||
| Exercise price | $ 0.93 | ||||||||||||||||||
| Allocated description | The Company allocated the $2,450,000 proceeds between the convertible note and warrant based on their relative fair values. The warrant valuation was determined using a Black-Scholes option-pricing model. Significant valuation inputs included the Company’s common stock price of $0.91 per share, exercise price of $0.93 per share, expected term of 5.0 years, risk-free rate of 4.0%, selected volatility of 85.0%, expected dividend rate of 0.0%, and 16,554,055 warrants outstanding. Based on these inputs, the calculated warrant value was $0.63 per warrant, resulting in an indicated fair value of $10,368,000. The fair value of the convertible note was determined using valuation techniques that considered the contractual note terms, conversion feature, most favored nation provision, Company-specific credit risk, market interest rates, expected volatility, and probability-weighted conversion scenarios. The valuation considered two scenarios: a no subsequent convertible instrument issuance before expiration scenario, with an indicated value of $3,418,000. For purposes of allocating the $2,450,000 proceeds at issuance, the Company used the relative fair values of the warrant and convertible note. Accordingly, $1,843,000 was allocated to the warrant and recorded in additional paid-in capital, and $607,000 was allocated to the note. The allocation resulted in a debt discount of $1,843,000, which will be amortized to interest expense over the five-year term of the note using the effective interest method. As of September 30, 2026, the note had a principal amount of $2,450,000, unamortized debt discount of approximately $1,776,000 and a net carrying amount of approximately $674,000. | ||||||||||||||||||
| Convertible Promissory Note [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Purchase of warrant | 8,000,000 | 10,666,667 | |||||||||||||||||
| Exercise price | $ 0.55 | $ 0.50 | |||||||||||||||||
| Securities Purchase Agreement Convertible Promissory Note [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Interest expense | 1,000 | $ 8,000 | 0 | ||||||||||||||||
| Allocated description | The Company allocated the $1,000,000 of proceeds between the convertible note and warrants based on their relative fair values in accordance with ASC 470-20-30-1 and ASC 470-20-30-2. The warrant valuation was determined using a Black-Scholes option-pricing model. Significant valuation inputs included the Company’s common stock price of $0.61 per share, exercise price of $0.50 per share, expected term of 3.0 years, risk-free interest rate of 4.2%, selected volatility of 85.0%, expected dividend rate of 0.0%, and 17,777,776 warrants outstanding. Based on these inputs, the calculated warrant value was $0.37 per warrant, resulting in an indicated fair value of $6,651,000. The fair value of the convertible note at issuance was determined using a binomial lattice model that considered the contractual note terms, conversion feature, Company-specific credit risk, market interest rates, expected volatility, and the Company’s redemption right. Significant valuation inputs included the Company’s common stock price of $0.61 per share, conversion price of $0.45 per share, contractual term of 5.0 years, risk-free interest rate of 4.2%, selected volatility of 85.0%, and discount rate of 13.25%. Based on these inputs, the indicated fair value of the convertible note at issuance was $1,531,000. For purposes of allocating the $1,000,000 of proceeds at issuance, the Company used the relative fair values of the warrants and convertible note. Accordingly, $813,000 was allocated to the warrants and recorded in additional paid-in capital, and $187,000 was allocated to the note. The allocation resulted in an initial debt discount of $813,000, which is being amortized to interest expense over the five-year contractual term of the note using the effective interest method. As of September 30, 2026, the note had a principal amount of $1,000,000, an unamortized debt discount of approximately $802,000, and a net carrying amount of approximately $198,000. | ||||||||||||||||||
| Securities Purchase Agreement Convertible Promissory Note One [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Allocated description | The Company allocated the $600,000 of proceeds between the convertible note and warrants based on their relative fair values in accordance with ASC 470-20-30-1 and ASC 470-20-30-2. The warrant valuation was determined using a Black-Scholes option-pricing model. Significant valuation inputs included the Company’s common stock price of $0.5615 per share, exercise price of $0.50 per share, expected term of 5.0 years, risk-free interest rate of 4.38%, selected volatility of 85.0%, expected dividend rate of 0.0%, and 10,666,667 warrants outstanding. Based on these inputs, the calculated warrant value was approximately $0.40 per warrant, resulting in an indicated fair value of approximately $4,271,000. The fair value of the convertible note at issuance was determined using a valuation approach that combined a discounted cash-flow analysis of the straight-debt component with an option-pricing analysis of the embedded conversion feature. The valuation considered the contractual note terms, conversion feature, Company-specific credit risk, market interest rates, expected volatility and the Company’s redemption right. Significant valuation inputs included the Company’s common stock price of $0.56per share, conversion price of $0.45 per share, contractual term of 5.0 years, risk-free interest rate of 4.38%, selected volatility of 85.0%, and a credit-adjusted discount rate of 14.43%. Based on these inputs, the indicated fair value of the convertible note at issuance was approximately $898,000. For purposes of allocating the $600,000 of proceeds at issuance, the Company used the relative fair values of the warrants and convertible note. Accordingly, approximately $496,000 was allocated to the warrants and recorded in additional paid-in capital, and approximately $104,000 was allocated to the note. The allocation resulted in an initial debt discount of approximately $496,000, which is being amortized to interest expense over the five-year contractual term of the note using the effective interest method pursuant to ASC 835-30-35. As of September 30, 2026, the note had a principal amount of $600,000, an unamortized debt discount of approximately $493,000, a net carrying amount of approximately $107,000 and accrued interest of approximately $2,000. Interest expense associated with the note for the three and nine months ended September 30, 2026 was approximately $5,000, including approximately $3,000 of debt-discount amortization. | ||||||||||||||||||
| Securities Purchase Agreement Convertible Promissory Note Two [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Allocated description | The Company allocated the $500,000 of proceeds between the convertible note and warrants based on their relative fair values in accordance with ASC 470-20-30-1 and ASC 470-20-30-2. The warrant valuation was determined using a Black-Scholes-Merton option-pricing model. Significant valuation inputs included the Company’s common stock price of $0.7411 per share, exercise price of $0.55 per share, expected term of 5.0 years, risk-free interest rate of 4.83%, selected volatility of 85.0%, expected dividend rate of 0.0%, and 8,000,000 warrants outstanding. Based on these inputs, the calculated warrant value was approximately $0.55154 per warrant, resulting in an indicated fair value of approximately $4,412,000. The fair value of the convertible note at issuance was determined using a component valuation approach consisting of a discounted cash flow analysis of the straight-debt component and a Black-Scholes approximation of the embedded conversion feature. The straight-debt analysis considered the contractual cash flows, five-year expected term, Company-specific credit risk and market interest rates. Significant valuation inputs included a principal amount of $500,000, contractual interest rate of 3.0%, five-year term, and a credit-adjusted market yield of 15.55%. The indicated fair value of the straight-debt component was approximately $280,000. The embedded conversion feature was valued using the Company’s common stock price of $0.7411 per share, conversion price of $0.50 per share, expected term of 5.0 years, risk-free interest rate of 4.83%, selected volatility of 85.0%, and expected dividend rate of 0.0%. The indicated value of the conversion feature was approximately $562,000, resulting in an indicated stand-alone fair value of the convertible note of approximately $841,000. For purposes of allocating the $500,000 of proceeds at issuance, the Company used the relative fair values of the warrants and convertible note. Accordingly, approximately $420,000 was allocated to the warrants and recorded in additional paid-in capital, and approximately $80,000 was allocated to the note. The allocation resulted in an initial debt discount of approximately $420,000, which is being amortized to interest expense over the five-year contractual term of the note using the effective interest method in accordance with ASC 835-30. The resulting effective interest rate is approximately 47.55%. As of September 30, 2026, the note had a principal amount of $500,000, an unamortized debt discount of approximately $419,000, and a net carrying amount of approximately $81,000, exclusive of accrued contractual interest. | ||||||||||||||||||
| Alset International Limited [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Interest rate | 3.00% | ||||||||||||||||||
| Interest expense | $ 38,000 | 0 | |||||||||||||||||
| Converted outstanding price | $ 0.74 | ||||||||||||||||||
| Purchase of warrant | 16,554,055 | ||||||||||||||||||
| Exercise price | $ 0.93 | ||||||||||||||||||
| Allocated description | The Company allocated the $2,450,000 proceeds between the convertible note and warrant based on their relative fair values. The warrant valuation was determined using a Black-Scholes option-pricing model. Significant valuation inputs included the Company’s common stock price of $0.91 per share, exercise price of $0.93 per share, expected term of 5.0 years, risk-free rate of 4.0%, selected volatility of 85.0%, expected dividend rate of 0.0%, and 16,554,055 warrants outstanding. Based on these inputs, the calculated warrant value was $0.63 per warrant, resulting in an indicated fair value of $10,368,000. The fair value of the convertible note was determined using valuation techniques that considered the contractual note terms, conversion feature, most favored nation provision, Company-specific credit risk, market interest rates, expected volatility, and probability-weighted conversion scenarios. The valuation considered two scenarios: a no subsequent convertible instrument issuance before expiration scenario, with an indicated value of $3,418,000. For purposes of allocating the $2,450,000 proceeds at issuance, the Company used the relative fair values of the warrant and convertible note. Accordingly, $1,843,000 was allocated to the warrant and recorded in additional paid-in capital, and $607,000 was allocated to the note. The allocation resulted in a debt discount of $1,843,000, which will be amortized to interest expense over the five-year term of the note using the effective interest method. As of September 30, 2026, the note had a principal amount of $2,450,000, unamortized debt discount of approximately $1,776,000 and a net carrying amount of approximately $674,000. | ||||||||||||||||||
| Alset, Inc. [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Converted outstanding price | $ 0.50 | $ 0.45 | $ 0.45 | ||||||||||||||||
| Alset, Inc. [Member] | Convertible Promissory Note [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Interest rate | 3.00% | ||||||||||||||||||
| Purchase of warrant | 8,000,000 | 10,666,667 | 17,777,776 | ||||||||||||||||
| Exercise price | $ 0.55 | $ 0.50 | $ 0.50 | ||||||||||||||||
| Alset, Inc. [Member] | Securities Purchase Agreement Convertible Promissory Note [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Interest expense | 1,000 | $ 8,000 | 0 | ||||||||||||||||
| Allocated description | The Company allocated the $1,000,000 of proceeds between the convertible note and warrants based on their relative fair values in accordance with ASC 470-20-30-1 and ASC 470-20-30-2. The warrant valuation was determined using a Black-Scholes option-pricing model. Significant valuation inputs included the Company’s common stock price of $0.61 per share, exercise price of $0.50 per share, expected term of 3.0 years, risk-free interest rate of 4.2%, selected volatility of 85.0%, expected dividend rate of 0.0%, and 17,777,776 warrants outstanding. Based on these inputs, the calculated warrant value was $0.37 per warrant, resulting in an indicated fair value of $6,651,000. The fair value of the convertible note at issuance was determined using a binomial lattice model that considered the contractual note terms, conversion feature, Company-specific credit risk, market interest rates, expected volatility, and the Company’s redemption right. Significant valuation inputs included the Company’s common stock price of $0.61 per share, conversion price of $0.45 per share, contractual term of 5.0 years, risk-free interest rate of 4.2%, selected volatility of 85.0%, and discount rate of 13.25%. Based on these inputs, the indicated fair value of the convertible note at issuance was $1,531,000. For purposes of allocating the $1,000,000 of proceeds at issuance, the Company used the relative fair values of the warrants and convertible note. Accordingly, $813,000 was allocated to the warrants and recorded in additional paid-in capital, and $187,000 was allocated to the note. The allocation resulted in an initial debt discount of $813,000, which is being amortized to interest expense over the five-year contractual term of the note using the effective interest method. As of September 30, 2026, the note had a principal amount of $1,000,000, an unamortized debt discount of approximately $802,000, and a net carrying amount of approximately $198,000. | ||||||||||||||||||
| Alset, Inc. [Member] | Securities Purchase Agreement Convertible Promissory Note One [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Allocated description | The Company allocated the $600,000 of proceeds between the convertible note and warrants based on their relative fair values in accordance with ASC 470-20-30-1 and ASC 470-20-30-2. The warrant valuation was determined using a Black-Scholes option-pricing model. Significant valuation inputs included the Company’s common stock price of $0.5615 per share, exercise price of $0.50 per share, expected term of 5.0 years, risk-free interest rate of 4.38%, selected volatility of 85.0%, expected dividend rate of 0.0%, and 10,666,667 warrants outstanding. Based on these inputs, the calculated warrant value was approximately $0.40 per warrant, resulting in an indicated fair value of approximately $4,271,000. The fair value of the convertible note at issuance was determined using a valuation approach that combined a discounted cash-flow analysis of the straight-debt component with an option-pricing analysis of the embedded conversion feature. The valuation considered the contractual note terms, conversion feature, Company-specific credit risk, market interest rates, expected volatility and the Company’s redemption right. Significant valuation inputs included the Company’s common stock price of $0.56per share, conversion price of $0.45 per share, contractual term of 5.0 years, risk-free interest rate of 4.38%, selected volatility of 85.0%, and a credit-adjusted discount rate of 14.43%. Based on these inputs, the indicated fair value of the convertible note at issuance was approximately $898,000. For purposes of allocating the $600,000 of proceeds at issuance, the Company used the relative fair values of the warrants and convertible note. Accordingly, approximately $496,000 was allocated to the warrants and recorded in additional paid-in capital, and approximately $104,000 was allocated to the note. The allocation resulted in an initial debt discount of approximately $496,000, which is being amortized to interest expense over the five-year contractual term of the note using the effective interest method pursuant to ASC 835-30-35. As of September 30, 2026, the note had a principal amount of $600,000, an unamortized debt discount of approximately $493,000, a net carrying amount of approximately $107,000 and accrued interest of approximately $2,000. Interest expense associated with the note for the three and nine months ended September 30, 2026 was approximately $5,000, including approximately $3,000 of debt-discount amortization. | ||||||||||||||||||
| Alset, Inc. [Member] | Securities Purchase Agreement Convertible Promissory Note Two [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Allocated description | The Company allocated the $500,000 of proceeds between the convertible note and warrants based on their relative fair values in accordance with ASC 470-20-30-1 and ASC 470-20-30-2. The warrant valuation was determined using a Black-Scholes-Merton option-pricing model. Significant valuation inputs included the Company’s common stock price of $0.7411 per share, exercise price of $0.55 per share, expected term of 5.0 years, risk-free interest rate of 4.83%, selected volatility of 85.0%, expected dividend rate of 0.0%, and 8,000,000 warrants outstanding. Based on these inputs, the calculated warrant value was approximately $0.55154 per warrant, resulting in an indicated fair value of approximately $4,412,000. The fair value of the convertible note at issuance was determined using a component valuation approach consisting of a discounted cash flow analysis of the straight-debt component and a Black-Scholes approximation of the embedded conversion feature. The straight-debt analysis considered the contractual cash flows, five-year expected term, Company-specific credit risk and market interest rates. Significant valuation inputs included a principal amount of $500,000, contractual interest rate of 3.0%, five-year term, and a credit-adjusted market yield of 15.55%. The indicated fair value of the straight-debt component was approximately $280,000. The embedded conversion feature was valued using the Company’s common stock price of $0.7411 per share, conversion price of $0.50 per share, expected term of 5.0 years, risk-free interest rate of 4.83%, selected volatility of 85.0%, and expected dividend rate of 0.0%. The indicated value of the conversion feature was approximately $562,000, resulting in an indicated stand-alone fair value of the convertible note of approximately $841,000. For purposes of allocating the $500,000 of proceeds at issuance, the Company used the relative fair values of the warrants and convertible note. Accordingly, approximately $420,000 was allocated to the warrants and recorded in additional paid-in capital, and approximately $80,000 was allocated to the note. The allocation resulted in an initial debt discount of approximately $420,000, which is being amortized to interest expense over the five-year contractual term of the note using the effective interest method in accordance with ASC 835-30. The resulting effective interest rate is approximately 47.55%. As of September 30, 2026, the note had a principal amount of $500,000, an unamortized debt discount of approximately $419,000, and a net carrying amount of approximately $81,000, exclusive of accrued contractual interest. | ||||||||||||||||||
| BMIC Loan [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Debt instrument face amount | $ 3,000,000 | 33,000 | 33,000 | $ 33,000 | 33,000 | ||||||||||||||
| Maturity date | October 2026 | ||||||||||||||||||
| Wilson Loan [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Debt instrument face amount | $ 3,000,000 | 145,000 | 145,000 | 145,000 | 145,000 | ||||||||||||||
| Maturity date | October 2026 | ||||||||||||||||||
| Alset Note [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Debt instrument face amount | 538,000 | 538,000 | 538,000 | ||||||||||||||||
| Interest expense | 36,000 | 3 | |||||||||||||||||
| Convertible Bond Investment [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Convertible bond investment fair value | $ 2,450,000 | ||||||||||||||||||
| Convertible Bond Investment [Member] | Alset International Limited [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Convertible bond investment fair value | $ 2,450,000 | ||||||||||||||||||
| Convertible Promissory Note [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Interest rate | 3.00% | 3.00% | 3.00% | ||||||||||||||||
| Maturity date | September 15, 2031 | August 17, 2031 | June 23, 2031 | ||||||||||||||||
| Convertible bond investment fair value | $ 500,000 | $ 600,000 | $ 1,000,000 | ||||||||||||||||
| Converted outstanding price | $ 0.45 | ||||||||||||||||||
| Purchase of warrant | 17,777,776 | ||||||||||||||||||
| Exercise price | $ 0.50 | ||||||||||||||||||
| Proceeds from issuance of convertible promissory note | $ 500,000 | $ 600,000 | $ 1,000,000 | ||||||||||||||||
| Convertible Promissory Note [Member] | Alset, Inc. [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Interest rate | 3.00% | 3.00% | |||||||||||||||||
| Maturity date | September 15, 2031 | August 17, 2031 | June 23, 2031 | ||||||||||||||||
| Convertible bond investment fair value | $ 500,000 | $ 600,000 | $ 1,000,000 | ||||||||||||||||
| Proceeds from issuance of convertible promissory note | $ 500,000 | $ 600,000 | $ 1,000,000 | ||||||||||||||||
| Note 4 [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Debt instrument face amount | $ 100,000 | $ 100,000 | |||||||||||||||||
| Interest rate | 8.00% | 8.00% | |||||||||||||||||
| Debt instrument maturity date | Aug. 29, 2025 | Aug. 29, 2025 | |||||||||||||||||
| Notes and loans receivable gross current | 83,000 | 83,000 | 83,000 | 86,000 | |||||||||||||||
| Note 5 [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Debt instrument face amount | $ 102,000 | ||||||||||||||||||
| Interest rate | 2.00% | ||||||||||||||||||
| Debt instrument maturity date | May 07, 2026 | May 07, 2026 | |||||||||||||||||
| Notes and loans receivable gross current | 110,000 | 110,000 | 110,000 | 110,000 | |||||||||||||||
| Note 6 [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Debt instrument face amount | $ 1,000,000 | ||||||||||||||||||
| Interest rate | 8.00% | ||||||||||||||||||
| Debt instrument maturity date | Jul. 26, 2024 | ||||||||||||||||||
| Notes and loans receivable gross current | $ 890,000 | $ 890,000 | 890,000 | 917,000 | |||||||||||||||
| BMI Capital International LLC [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Number of shares issued | $ 100,000 | ||||||||||||||||||
| Equity method investment | $ 13,000 | 4,000 | |||||||||||||||||
| DSS Securities, Inc. [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Equity method investment ownership percentage | 14.90% | ||||||||||||||||||
| BMI Capital International LLC [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Equity method investment ownership percentage | 24.90% | 24.90% | 24.90% | 24.90% | |||||||||||||||
| BMI Capital Inc [Member] | Note 4 [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Equity method investment ownership percentage | 24.90% | 24.90% | |||||||||||||||||
| BMI Capital Inc [Member] | Note 5 [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Equity method investment ownership percentage | 24.90% | ||||||||||||||||||
| Alset International Limited [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Investment owned | 127,179,291 | 127,179,291 | 127,179,291 | ||||||||||||||||
| Percentage of outstanding shares | 4.00% | ||||||||||||||||||
| Fair value of marketable securities | $ 1,399,000 | $ 1,399,000 | $ 1,399,000 | 2,277,000 | |||||||||||||||
| Unrealized gain loss on investments | 877,000 | 51,000 | |||||||||||||||||
| DSS Securities, Inc. [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Number of shares issued | $ 100,000 | ||||||||||||||||||
| Outstanding membership interest | 10.00% | ||||||||||||||||||
| Alset, Inc. [Member] | |||||||||||||||||||
| Related Party Transaction [Line Items] | |||||||||||||||||||
| Debt instrument face amount | $ 538,000 | $ 538,000 | $ 538,000 | $ 512,000 | |||||||||||||||
| Interest rate | 6.75% | 6.75% | 6.75% | ||||||||||||||||
| Convertible Notes Payable | $ 500,000 | ||||||||||||||||||
| Shares Issued, Price Per Share | $ 0.86 | ||||||||||||||||||
| Interest expense | $ 36,000 | $ 3,000 | |||||||||||||||||